Immunofluorescence imaging as a tool for studying the pharmacokinetics of a human monoclonal single chain fragment antibody

IEEE Transactions on Medical Imaging

Volumn 21, Issue 10, 2002, Pages 1317-1323

  Ramjiawan, Bram ^a,b   Ariano, Robert E ^b   Mantsch, Henry H ^a   Maiti, Pradip ^c   Jackson, Michael ^a,b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

^c Viventia Biotech Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENCE; IMMUNOLOGY; MONOCLONAL ANTIBODIES; PHARMACOKINETICS; TUMORS;

IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE IMAGING;

MEDICAL IMAGING;

CANCER ANTIBODY; HYBRID PROTEIN; IMMUNOGLOBULIN FRAGMENT; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; COMPARATIVE STUDY; EVALUATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMAGE ENHANCEMENT; IMMUNOLOGY; MALE; MELANOMA; METABOLISM; METHODOLOGY; MIDDLE AGED; MOUSE; NUDE MOUSE; PHARMACOKINETICS; REFERENCE VALUE; SHOULDER; SKIN TUMOR; TISSUE DISTRIBUTION; VIDEORECORDING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMAGE ENHANCEMENT; IMMUNOGLOBULIN FRAGMENTS; MALE; MELANOMA; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; PHARMACOKINETICS; RECOMBINANT FUSION PROTEINS; REFERENCE VALUES; SHOULDER; SKIN NEOPLASMS; TISSUE DISTRIBUTION; VIDEO RECORDING;

EID: 0036826175     PISSN: 02780062     EISSN: None     Source Type: Journal    
DOI: 10.1109/TMI.2002.806275     Document Type: Article

References (38)

1. T. A. Waldmann, "Monoclonal antibodies in diagnosis and therapy," Sci., vol. 252, pp. 1657-1662, 1991.
2. D. L. Shawler, R. M. Bartholomew, L. M. Smith, and R. O. Dilman, "Human immune response to multiple injections of murine monoclonal IgG," J. Immunol., vol. 135, pp. 1530-1535, 1995.
3. J. Hakimi et al., "Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys," J. Immunol., vol. 147, pp. 1352-1359, 1991.
4. K. A. Chester and R. E. Hawkins, "Clinical issues in antibody design," Trends. Biotechnol., vol. 13, pp. 294-300, 1995.
5. P. K. Maiti, M. D. Dan, A. K. Prasher, X. Y. Yuan, D. V. Duncan, X. He, A. D. Friesen, and H. A. Kaplan, "Development and characterization of pancarcinoma specific human monoclonal antibody H11 (NovoMAb-G2)," Biotechnol. Int., pp. 85-93, 1998.
6. R. Reilly, P. K. Maiti, R. Kiarash, A. K. Prashar, D. G. Fast, J. Entwistle, M. Dan, S. A. Narang, S. Foote, and H. A. Kaplan, "Rapid imaging of human melanoma xenografts using an scFv fragment of the human monoclonal antilbody H11 latbelled with 111In," Nucl. Med. Commun., vol. 22, pp. 587-595, 2001.
7. G. Pavlinkova, D. Colcher, B. J. Booth, A. Goel, and S. K. Batra, "Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct," Cancer Immunol. Immunother., vol. 49, pp. 267-275, 2000.
8. M. D. Pegram, A. Lipton, D. F. Hayes, B. L. Weber, J. M. Baselga, D. Tripathy, D. Baly, S. A. Baughman, T. Twaddell, J. A. Glaspy, and D. J. Slamon, "Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment," J. Clin. Oncol., vol. 16, pp. 2659-2671, 1998.
9. H. G. Massoud TF et al., "Principles and phlosophy of modeling in biomedical research," FASEB J., vol. 12, pp. 275-285, 1998.
10. R. Jain, N. Podworny, G. I. Anderson, and E. H. Schemitsch, "Assessment of the relationship between standard probe and implantable fiber measurements of cortical bone blood flow: A canine study," Calcif. Tissue Int., vol. 59, pp. 64-69, 1996.
11. F. N. Jiang, A. M. Richter, A. K. Jain, J. G. Levy, and C. Smits, "Biodistribution of a benzoporphyrin derivative-monoclonal antibody conjugate in A549-tumor-bearing nude mice," Biotechnol. Ther., vol. 4, pp. 43-61, 1993.
12. V. V. Lazarev, R. A. Roth, Y. Kanzakevich, and J. Hang, "Detection of premalignant oral lesions in hamsters with an endoscopic fluorescence imaging system," Cancer, vol. 85, pp. 1421-1429, 1999.
13. M. W. Arnold, S. Schneebaum, A. Berens, C. Mojzisik, G. Hinkle, and J. Martin-EW, "Radioimmunoguided surgery challenges traditional decision making in patients with primary colorectal cancer," Surgery, vol. 112, pp. 624-629, 1992.
14. K. J. Baranowska, G. V. Dalrymple, S. M. Quadri, and K. A. Harrison, "Radiolabeling of antibodies for therapy and diagnosis," Meth. Mol. Biol., vol. 51, pp. 423-439, 1995.
15. L. M. Cobb and J. L. Humm, "Radioimmunotherapy of malignancy using antibody targeted radionuclides," Br. J. Cancer, vol. 54, p. 863, 1999.
16. D. M. Goldenberg and S. M. Larson, "Radioimmunodetection in cancer identification," J. Nucl. Med., vol. 33, pp. 803-814, 1992.
17. B. Ramjiawan, P. Maiti, A. Aftanas, H. Kaplan, D. Fast, H. Mantsch, and M. Jackson, "Non-invasive localization of tumours by immunofluorescence imaging using a single chain Fv fragment of a human monoclonal antibody with broad cancer specificity," Cancer, vol. 89, pp. 1134-1144, 2000.
18. R. B. Mujumdar, L. A. Ernst, S. R. Mujumdar, C. J. Lewis, and A. S. Waggoner, "Cyanine dye labeling reagents: Sulfoindocyanine succinimidyl esters," Bioconjug. Chem., vol. 4, pp. 105-111, 1993.
19. J. Lim and R. W. Flower, "Indocyanine green angiography," Int. Ophthalmol. Clin., vol. 35, pp. 59-70, 1995.
20. I. Pathak, N. L. Davis, Y. N. Hsiang, N. F. Quenville, and B. Palcic, "Detection of squamous neoplasia by fluorescence imaging comparing porfimer sodium fluorescence to tissue autofluorescence in the hamster cheek-pouch model," Amer. J. Surg. vol. 170, pp. 423-426, 1995.
21. S. A. D'Aregenio DZ, "A program package for simulation and parameter estimation in pharmacokinetic systems," Comput. Programs Biomed., vol. 9, pp. 115-134, 1979.
22. R. K. Jain, "Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors," Cancer Res., vol. 50, pp. 814s-819s, 1990.
23. ____, "Delivery of molecular medicine to solid tumors," Sci., vol. 271, pp. 1079-1080, 1996.
24. J. G. Jurcic, D. A. Scheinberg, and A. N. Houghton, "Monoclonal antibody therapy of cancer," Cancer Chemo. Biol. Resp. Mod., vol. 15, pp. 152-175, 1994.
25. G. D. Behr TM and W. Becker, "Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: Present status, future prospects and limitations," Eur. J. Nucl. Med., vol. 25, pp. 201-212, 1998.
26. B. M. Brenner, W. M. Dean, and C. R. Robertson, "The physiological basis of glomerular ultrafiltration," in Kidney and Urinary Tract Physiology, K. Thurau, Ed. London, U.K.: Butterworth-Heinemann, 1974, p. 235.
27. E. Benjamini and S. Leskowitz, Immunology A Short Course, 2nd ed. New York: Alan R. Liss, 1998.
28. R. L. Ceriani, E. W. Blank, J. R. Couto, and J. A. Peterson, "Biological activity of two humanized antibodies against two different breast cancer antigens and comparison to their original murine forms," Cancer Res., vol. 55, pp. 5852s-5856s, 1995.
29. C. R. Borrebaeck CAK, "Human therapeutic antibodies," Current Opin. Pharm., vol. 1, 2001.
30. R. O. Dillman, "Monoclonal antibodies in the treatment of malignancy: Basic concepts and recent developments," Cancer Invest., vol. 19, pp. 833-841, 2001.
31. H. J. Haisma, M. A. Kessel, C. Silva, M. van-Muijen, J. C. Roos, H. Bril, H. J. Martens, R. McCabe, and E. Boven, "Human IgM monoclonal antibody 16.88: Pharmacokinetics and distribution in mouse and man," Br. J. Cancer Suppl., vol. 10, pp. 40-43, 1990.
32. R. J. Ditzel H et al., "Tumour detection with 131 I-labeled human monoclonal antibody COU-1 in patients with suspected colorectal carcinoma," Cancer Res., vol. 53, pp. 5920-5928, 1993.
33. S. Yaghoubi, J. R. Barrio, M. Bahlbom, M. Iyer, M. Namavari, S. Satyamurthy, R. Goldman, H. R. Herschman, M. E. Phelps, and S. S. Gambhir, "Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: A reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression," J. Nucl. Med., vol. 42, no. 8, pp. 1235-1237, 2001.
34. R. J. Callahan, A. Bogdanov, A. J. Fischman, T. J. Brady, and R. Weissleder, "Preclinical evaluation and phase I clinical trial of a 99 m-Tc-labeled synthetic polymer used in blood pool imaging," Amer. J. Roentgenol., vol. 171, no. 1, pp. 137-143, 1998.
35. P. M. Pietersz GA and K. A. Chester, "Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99 m-labled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody," J. Nucl. Med., vol. 39, pp. 47-56, 1998.
36. R. Weissleder, C. H. Tung, U. Mahmood, and A. Bogdanov, "In vivo imaging of tumors with protease-activated near-infrared fluorescent probes," Nat. Biotechnol., vol. 17, pp. 375-378, 1999.
37. R. Weissleder, "Scaling down imaging: Molecular mapping of cancer in mice," Nature Rev. Cancer, vol. 2, pp. 11-18, 2002.
38. B. Ramjiawan, P. Maiti, H. Kaplan, D. Fast, H. Mantsch, and M. Jackson, "In vivo monitoring of the distribution of a monoclonal antibody fragment," Vibrat. Spectro., vol. 28, pp. 177-188, 2002.